APOC-III: a gatekeeper in controlling triglyceride metabolism

A Giammanco, R Spina, AB Cefalù… - Current atherosclerosis …, 2023 - Springer
Abstract Purpose of Review Apolipoprotein C-III (ApoC-III) is a widely known player in
triglyceride metabolism, and it has been recently recognized as a polyhedric factor which …

Triglyceride and triglyceride-rich lipoproteins in atherosclerosis

BH Zhang, F Yin, YN Qiao, SD Guo - Frontiers in Molecular …, 2022 - frontiersin.org
Cardiovascular disease (CVD) is still the leading cause of death globally, and
atherosclerosis is the main pathological basis of CVDs. Low-density lipoprotein cholesterol …

Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance

CJ Packard, A Pirillo, S Tsimikas… - Cardiovascular …, 2023 - academic.oup.com
The availability of pharmacological approaches able to effectively reduce circulating LDL
cholesterol (LDL-C) has led to a substantial reduction in the risk of atherosclerosis-related …

[HTML][HTML] Apolipoprotein C3: form begets function

KE Bornfeldt - Journal of Lipid Research, 2024 - Elsevier
Increased circulating levels of apolipoprotein C3 (APOC3) predict cardiovascular disease
(CVD) risk in humans, and APOC3 promotes atherosclerosis in mouse models. APOC3's …

Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations

MR Taskinen, E Björnson, N Matikainen… - JCI …, 2022 - pmc.ncbi.nlm.nih.gov
Background Apolipoprotein C-III (apoC-III) is a regulator of triglyceride (TG) metabolism, and
due to its association with risk of cardiovascular disease, is an emergent target for …

[HTML][HTML] Multiplexed assays of human disease-relevant mutations reveal UTR dinucleotide composition as a major determinant of RNA stability

JY Su, YL Wang, YT Hsieh, YC Chang, CH Yang… - eLife, 2025 - elifesciences.org
Untranslated regions (UTRs) contain crucial regulatory elements for RNA stability,
translation and localization, so their integrity is indispensable for gene expression …

Contribution of circulating Mfge8 to human T2DM and cardiovascular disease

M Rout, MW Malone-Perez, G Park, M Lerner… - Gene, 2024 - Elsevier
MFGE8 is a major exosome (EV) protein known to mediate inflammation and atherosclerosis
in type 2 diabetes mellitus (T2DM) in animal studies. The pathophysiological role of this …

Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populations

M Rout, GS Wander, S Ralhan… - Therapeutic …, 2023 - journals.sagepub.com
Background: Genome-wide polygenic risk scores (PRS) have shown high specificity and
sensitivity in predicting type 2 diabetes (T2D) risk in Europeans. However, the PRS-driven …

[HTML][HTML] CRISPR-Cas9 in Cardiovascular Medicine: Unlocking New Potential for Treatment

K Bonowicz, D Jerka, K Piekarska, J Olagbaju… - Cells, 2025 - mdpi.com
Cardiovascular diseases (CVDs) remain a significant global health challenge, with many
current treatments addressing symptoms rather than the genetic roots of these conditions …

Insights into causal cardiovascular risk factors from mendelian randomization

CM Schooling, JV Zhao - Current Cardiology Reports, 2023 - Springer
Abstract Purpose of the Review This review summarizes major insights into causal risk
factors for cardiovascular disease (CVD) by using Mendelian randomization (MR) to obtain …